Suchergebnisse - "Viiklepp, Piret"
-
1
Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis
ISSN: 0140-6736, 1474-547X, 1474-547XVeröffentlicht: England Elsevier Ltd 08.08.2020Veröffentlicht in The Lancet (British edition) (08.08.2020)“… HIV-infection is associated with increased mortality during multidrug-resistant tuberculosis treatment, but the extent to which the use of antiretroviral …”
Volltext
Journal Article -
2
Aminoglycosides and Capreomycin in the Treatment of Multidrug-resistant Tuberculosis: Individual Patient Data Meta-analysis of 12 030 Patients From 25 Countries, 2009-2016
ISSN: 1537-6591, 1537-6591Veröffentlicht: United States 06.12.2021Veröffentlicht in Clinical infectious diseases (06.12.2021)“… As new drugs are developed for multidrug-resistant tuberculosis (MDR-TB), the role of currently used drugs must be reevaluated. We combined individual-level …”
Weitere Angaben
Journal Article -
3
Estimating treatment importance in multidrug‐resistant tuberculosis using Targeted Learning: An observational individual patient data network meta‐analysis
ISSN: 0006-341X, 1541-0420, 1541-0420Veröffentlicht: England Blackwell Publishing Ltd 01.09.2020Veröffentlicht in Biometrics (01.09.2020)“… Persons with multidrug‐resistant tuberculosis (MDR‐TB) have a disease resulting from a strain of tuberculosis (TB) that does not respond to at least isoniazid …”
Volltext
Journal Article -
4
Association of indicators of extensive disease and rifampin-resistant tuberculosis treatment outcomes: an individual participant data meta-analysis
ISSN: 0040-6376, 1468-3296, 1468-3296Veröffentlicht: England BMJ Publishing Group Ltd and British Thoracic Society 01.02.2024Veröffentlicht in Thorax (01.02.2024)“… BackgroundIndicators of extensive disease—acid fast bacilli (AFB) smear positivity and lung cavitation—have been inconsistently associated with clinical …”
Volltext
Journal Article -
5
Modeling treatment effect modification in multidrug-resistant tuberculosis in an individual patientdata meta-analysis
ISSN: 1477-0334, 1477-0334Veröffentlicht: England 01.04.2022Veröffentlicht in Statistical methods in medical research (01.04.2022)“… Effect modification occurs while the effect of the treatment is not homogeneous across the different strata of patient characteristics. When the effect of …”
Weitere Angaben
Journal Article -
6
Treatment Outcomes in Multidrug-Resistant Tuberculosis
ISSN: 0028-4793, 1533-4406, 1533-4406Veröffentlicht: United States Massachusetts Medical Society 15.09.2016Veröffentlicht in The New England journal of medicine (15.09.2016)“… Multidrug-resistant tuberculosis is a major global challenge. This report examines the definition of treatment success and its effect on determining cure. To …”
Volltext
Journal Article -
7
Evaluating the performance of propensity score matching based approaches in individual patient data meta-analysis
ISSN: 1471-2288, 1471-2288Veröffentlicht: London BioMed Central 23.11.2021Veröffentlicht in BMC medical research methodology (23.11.2021)“… Background Individual-patient data meta-analysis (IPD-MA) is an increasingly popular approach because of its analytical benefits. IPD-MA of observational …”
Volltext
Journal Article -
8
Spatiotemporal dynamics of drug‐resistant Mycobacterium tuberculosis: Contrasting trends and implications for tuberculosis control in EU high‐priority country
ISSN: 1865-1674, 1865-1682, 1865-1682Veröffentlicht: Germany John Wiley & Sons, Inc 01.03.2021Veröffentlicht in Transboundary and emerging diseases (01.03.2021)“… Different and contrasting trends related to human migration and the implementation of health control programmes influence the spread of drug‐resistant …”
Volltext
Journal Article -
9
Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis
ISSN: 2213-2619, 2213-2619Veröffentlicht: England 01.04.2018Veröffentlicht in The lancet respiratory medicine (01.04.2018)“… Isoniazid-resistant, rifampicin-susceptible (INH-R) tuberculosis is the most common form of drug resistance, and is associated with failure, relapse, and …”
Weitere Angaben
Journal Article -
10
Surgery as an Adjunctive Treatment for Multidrug-Resistant Tuberculosis: An Individual Patient Data Metaanalysis
ISSN: 1537-6591Veröffentlicht: United States 01.04.2016Veröffentlicht in Clinical infectious diseases (01.04.2016)“… Medical treatment for multidrug-resistant (MDR)-tuberculosis is complex, toxic, and associated with poor outcomes. Surgical lung resection may be used as an …”
Weitere Angaben
Journal Article -
11
Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies
ISSN: 2213-2619Veröffentlicht: England 01.03.2015Veröffentlicht in The lancet respiratory medicine (01.03.2015)“… Sputum culture conversion is often used as an early microbiological endpoint in phase 2 clinical trials of tuberculosis treatment on the basis of its assumed …”
Weitere Angaben
Journal Article -
12
A successful introduction to a non-expert setting of the thin-layer agar Colour Test as an indirect phenotypic drug susceptibility test for Mycobacterium tuberculosis
ISSN: 1201-9712, 1878-3511, 1878-3511Veröffentlicht: Canada Elsevier Ltd 01.03.2021Veröffentlicht in International journal of infectious diseases (01.03.2021)“… •Results from the thin-layer agar MDR/XDR-TB Colour Test are highly reproducible.•Implementation of the thin-layer agar Colour Test does not require skilled …”
Volltext
Journal Article -
13
Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries
ISSN: 1073-449X, 1535-4970, 1535-4970Veröffentlicht: United States American Thoracic Society 01.08.2018Veröffentlicht in American journal of respiratory and critical care medicine (01.08.2018)“… Multidrug-resistant tuberculosis (MDR-TB) is a major burden to public health in Europe. Reported treatment success rates are around 50% or less, and cure rates …”
Volltext
Journal Article -
14
National lung cancer screening program feasibility study in Estonia
ISSN: 2753-670X, 2753-670XVeröffentlicht: England Oxford University Press 01.06.2023Veröffentlicht in Interdisciplinary cardiovascular and thoracic surgery (01.06.2023)“… Abstract OBJECTIVES The main aim of the lung cancer screening (LCS) feasibility study was to investigate the plausibility of and bottlenecks to systematic …”
Volltext
Journal Article -
15
Treatment outcomes of MDR-TB and HIV co-infection in Europe
ISSN: 1399-3003, 1399-3003Veröffentlicht: England 01.06.2017Veröffentlicht in The European respiratory journal (01.06.2017)Weitere Angaben
Journal Article -
16
Group 5 drugs for multidrug-resistant tuberculosis: individual patient data meta-analysis
ISSN: 1399-3003Veröffentlicht: England 01.01.2017Veröffentlicht in The European respiratory journal (01.01.2017)“… The role of so-called "group 5" second-line drugs as a part of antibiotic therapy for multidrug-resistant tuberculosis (MDR-TB) is widely debated. We performed …”
Weitere Angaben
Journal Article -
17
Drug Susceptibility Patterns in MDR-TB Patients: Challenges for Future Regimen Design. A Cross-Sectional Study
ISSN: 1932-6203, 1932-6203Veröffentlicht: United States Public Library of Science 11.11.2015Veröffentlicht in PloS one (11.11.2015)“… Globally, there is substantial concern regarding the challenges of treating complex drug resistance patterns in multidrug resistant tuberculosis cases …”
Volltext
Journal Article -
18
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
ISSN: 0140-6736, 1474-547X, 1474-547XVeröffentlicht: England Elsevier Ltd 08.09.2018Veröffentlicht in The Lancet (British edition) (08.09.2018)“… Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed to estimate the association of treatment success and death with the use of …”
Volltext
Journal Article -
19
Correction to: Reply to van Deun and Decroo
ISSN: 1537-6591, 1537-6591Veröffentlicht: United States 30.05.2022Veröffentlicht in Clinical infectious diseases (30.05.2022)Weitere Angaben
Journal Article -
20
Reply to van Deun and Decroo
ISSN: 1537-6591, 1537-6591Veröffentlicht: United States 15.06.2021Veröffentlicht in Clinical infectious diseases (15.06.2021)Weitere Angaben
Journal Article